AKAM vs LPCN · P/E 27, rev $2.17B vs rev $309.5K
Akamai Technologies Inc (AKAM) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the AKAM and LPCN stock pages for the full models.
Not investment advice.